Get an alert when MEDIMMUNE LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-12-25 (in 7mo)

Last made up 2025-12-11

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

-£547M

+73.1% vs 2023

Employees

202

-12.6% vs 2023

Profit before tax

£814M

+72.8% vs 2023

Name history

Renamed 1 time since incorporation

  1. MEDIMMUNE LIMITED 2007-10-29 → present
  2. CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED 1989-12-11 → 2007-10-29

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £2,206,000,000£2,595,000,000
Operating profit £621,000,000£935,000,000
Profit before tax £471,000,000£814,000,000
Net profit £255,000,000£1,489,000,000
Cash
Total assets less current liabilities -£1,643,000,000-£276,000,000
Net assets -£2,033,000,000-£547,000,000
Equity -£2,033,000,000-£547,000,000
Average employees 231202
Wages £20,000,000£18,000,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 28.2%36.0%
Net margin 11.6%57.4%
Return on capital employed -37.8%-338.8%
Gearing (liabilities / total assets) 207.6%121.8%
Current ratio 0.20x0.35x
Interest cover 4.14x7.73x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Based on their assessment of the Company's financial position, they continue to adopt the going concern basis in preparing the Financial Statements.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

13 active · 55 resigned

Name Role Appointed Born Nationality
JOHNSTONE, Camilla Jane Secretary 2019-09-16
BOWDEN, Matthew Shaun Director 2019-02-27 Dec 1977 British
BRINDICCI, Caterina Director 2024-06-29 Jan 1976 Italian
COLLINS, Iain Alistair Director 2017-05-31 Dec 1970 British
DE GIORGIO-MILLER, Alexander Director 2024-06-29 Feb 1977 British
DOBBER, Rudi Director 2024-06-29 Nov 1964 Dutch
GALBRAITH, Susan Director 2024-06-29 Oct 1965 British
HARROP, Elaine Director 2024-06-29 Aug 1974 British
JERMUTUS, Lutz Director 2025-02-10 Mar 1971 British,German
SAMBROOK, Sally Director 2024-06-29 Feb 1973 British
SARIN, Aradhana Director 2024-06-29 Apr 1974 American
STEPHENS, Christine Director 2024-06-29 Apr 1971 British
TATTERSALL, Hannah Victoria Director 2025-05-01 Jul 1987 British
Show 55 resigned officers
Name Role Appointed Resigned
BERTRAND, William Charles Secretary 2007-10-19 2013-04-26
CONACHER, Matthew Ian Secretary 2017-01-18 2019-09-16
HARDEN, Edward Highton Secretary 1992-03-01
HOSKINS, Justin Wilbert Secretary 2005-03-31 2006-09-22
JACKSON-TURNER, Katie Louise Secretary 2015-07-15 2017-01-18
JOHNSTON, Edward Conor Secretary 2008-02-01 2012-08-21
KEMP, Adrian Charles Noel Secretary 2006-09-22 2007-10-19
KEMP, Adrian Charles Noel Secretary 2006-09-22 2007-10-19
MELLETT, Diane Secretary 1997-12-12 2005-03-31
NIXON, Anthony Michael Secretary 1997-12-12
O'GRADY, Claire-Marie Secretary 2013-10-25 2015-07-31
ASTON, John Christopher Director 1996-09-02 2006-09-22
ASTON, Roger Director 1996-06-18 1997-12-31
ASTON, Roger Director 1996-03-12 1996-06-18
BERTRAND, William Charles Director 2007-09-11 2008-02-01
BICKER, Uwe, Professor Director 1999-02-06 2006-02-03
BRIMICOMBE, Ian Martin David Director 2013-12-20 2017-05-31
BROWN, John Robert, Dr Director 2005-09-12 2006-02-03
CAMERON, Hamish Director 2006-06-22 2007-07-13
CHAMBRE, Peter Alan Director 2002-04-08 2006-06-30
CHISWELL, David Director 1995-12-19 2002-03-31
CODD, Edward Daryl Director 1995-04-28 1995-04-28
CODD, Edward Daryl Director 1995-04-28
CUMMING, Alistair Cameron David Director 1998-03-01 1998-11-29
FISHBURN, Natalie Director 2024-06-29 2024-11-29
FOGHT, James L Director 1996-11-04 2003-02-07
GARLAND, Peter Bryan, Professor Director 2004-01-30
GLOVER, David Roy, Doctor Director 1997-07-11 2005-02-04
GRIGG, Geoffrey Walter Director 1996-06-18
HARPER, Paul Bernard Director 1995-03-01 1996-01-02
HOOKWAY, Paul Hamilton Director 1996-06-18 1996-11-11
HOSKINS, Justin Wilbert Director 2007-09-11 2010-04-30
JACKSON-TURNER, Katie Louise Director 2015-07-15 2019-02-27
JALLAL, Bahija Director 2010-04-30 2013-12-31
JOHNSON, Kevin Stuart, Dr Director 1997-07-11 2003-06-19
KEMP, Adrian Charles Noel Director 2013-12-20 2025-05-01
KIENER, Peter Alec Director 2008-02-01 2009-09-04
KLUG, Aaron, Professor Sir Director 2006-02-03
LUNDBERG, Jan Magnus Director 2006-06-22 2008-02-01
MARSHALL, Christopher John Director 2004-09-24 2006-02-03
MELLETT, Diane Director 2005-02-04 2006-09-22
NEILSEN, Eigil Director 1995-12-08
NICHOLSON, Paul Anthony, Doctor Director 1999-02-06 2006-02-03
O'GRADY, Claire-Marie Director 2013-12-20 2015-07-31
OSBOURN, Jane Katharine, Dr Director 2008-07-14 2013-12-31
PANELLA, Pablo Director 2024-06-29 2026-02-01
PATTERSON, John Simon, Dr Director 2006-06-22 2007-09-11
RINGROSE, Peter Stuart, Doctor Director 2003-02-10 2006-02-03
STAGEMAN, John Frederick Director 2008-02-01 2008-07-14
STAVLING, Ake Bo Tage Director 2002-12-02 2006-02-03
STOCKER, John Wilcox, Doctor Director 1995-03-05 2006-02-03
SYMONDS, Jonathan Richard Director 2006-06-22 2007-07-27
WEISBROD, Stuart T Director 1996-06-07 1998-09-30
WILLIAMS, Andrew James Director 2010-04-30 2013-12-31
WINTER, Gregory Paul, Sir Director 1994-09-13 1996-05-10

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Cambridge Antibody Technology Group Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 313 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2024-11-27 RESOLUTIONS Resolution
  • 2024-11-27 MA Memorandum articles
Date Type Category Description
2026-02-09 TM01 officers Termination director company with name termination date PDF
2025-12-19 CS01 confirmation-statement Confirmation statement with updates PDF
2025-08-07 AA accounts Accounts with accounts type full
2025-05-02 AP01 officers Appoint person director company with name date PDF
2025-05-01 TM01 officers Termination director company with name termination date PDF
2025-02-11 AP01 officers Appoint person director company with name date PDF
2024-12-13 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-11-29 TM01 officers Termination director company with name termination date PDF
2024-11-27 RESOLUTIONS resolution Resolution
2024-11-27 MA incorporation Memorandum articles
2024-08-28 CH01 officers Change person director company with change date PDF
2024-08-07 AA accounts Accounts with accounts type full
2024-07-10 AP01 officers Appoint person director company with name date PDF
2024-07-10 AP01 officers Appoint person director company with name date PDF
2024-07-10 AP01 officers Appoint person director company with name date PDF
2024-07-10 AP01 officers Appoint person director company with name date PDF
2024-07-10 AP01 officers Appoint person director company with name date PDF
2024-07-10 AP01 officers Appoint person director company with name date PDF
2024-07-10 AP01 officers Appoint person director company with name date PDF
2024-07-10 AP01 officers Appoint person director company with name date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
5

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page